Page last updated: 2024-08-24

topotecan and nifurtimox

topotecan has been researched along with nifurtimox in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forman, E; Greenlaw, C; Kalkunte, S; McCarten, K; Saulnier Sholler, GL1
Ashikaga, T; Bergendahl, GM; Bingham, PM; Brard, L; Ferguson, WS; Heath, BW; Higgins, TJ; Homans, AC; Kamen, BA; Lenox, SR; Saulnier Sholler, GL; Singh, AP; Slavik, MA1
Bruchelt, G; Cabanillas Stanchi, KM; Handgretinger, R; Holzer, U1

Trials

1 trial(s) available for topotecan and nifurtimox

ArticleYear
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Male; Maximum Tolerated Dose; Neuroblastoma; Nifurtimox; Recurrence; Topotecan; Treatment Outcome

2011

Other Studies

2 other study(ies) available for topotecan and nifurtimox

ArticleYear
Antitumor activity of nifurtimox observed in a patient with neuroblastoma.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chagas Disease; Child, Preschool; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Neuroblastoma; Nifurtimox; Recurrence; Remission Induction; Tomography, X-Ray Computed; Topotecan; Treatment Outcome

2006
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
    Cancer biology & therapy, 2015, Volume: 16, Issue:9

    Topics: Aerobiosis; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Gene Expression; Glycolysis; Humans; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nifurtimox; Nuclear Proteins; Oncogene Proteins; Oxidative Stress; Proto-Oncogene Mas; Reactive Oxygen Species; Topotecan

2015